Massivemarkets

Nasdaq: ATTO · Listed Aug 5, 2026

Attovia Therapeutics IPO

IPO price

$17.00

Attovia Therapeutics (ATTO) priced its IPO at $17.00 a share and has traded on Nasdaq since Aug 5, 2026.

ATTO today$15.53-8.65%since IPO15-min delayed · as of 5:19:45 PM EST on Nov 18, 2026

See the ATTO quote

First trading day · Aug 5, 2026

IPO price 17.00VWAP 21.68first trade 21.00+23.53% from the IPO pricehigh 22.57$21.96volume · rising bars above the line, falling bars below312.03K12:154:00
IPO price
$17.00
the top of the range of $15 to $17
First trade
$21.00
+23.53% from the IPO price
First-day last trade
$21.96
+29.18% from the IPO price, regular session
Raise
$289M
before the underwriters' option

These numbers are from the first trading day, Aug 5, 2026.

How ATTO did against the market

ATTO against the market, from its first trade at 12:15 ET to the last trade of the session.

ATTO from its first trade
+4.57%
Against the market (QQQ)
+5.0 pts

ATTO rose 4.6% from its first trade to the last trade of the session. That is 5.0 points better than the market.

Same-day moves do not show that ATTO caused them. The market is QQQ, the Nasdaq-100 ETF.

The debut race

ATTO against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%ATTO +29.79%

The IPO scoreboard

ATTO against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

ATTO against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Attovia Therapeutics '26$289M+23.53%+29.18%+10.06%+29.79%
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Attovia Therapeutics IPO offers 17M shares to raise $289M, before any underwriters' option.

$13$15$16$17$19
Expected price range
$15 to $17
IPO price
$17.00
Shares offered
17M
Money raised
$289M
Listing date
Aug 5, 2026
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Attovia Therapeutics$289M

Where ATTO ranks

Attovia Therapeutics's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • ATTO$709.92M

ATTO news

The latest news and headlines about Attovia Therapeutics (ATTO).

Filings and the company

What Attovia Therapeutics has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Attovia Therapeutics discloses to the SEC on Form 8-K.

  • The Company recently announced positive topline 12-week results from its Phase 1b study of ATTO-1310, a next-generation anti-IL-31 ATTOBODY-based precision itch therapy, in patients with chronic pruritus ("CP") and high-itch atopic dermatitis ("AD").

  • On September 2, 2026, Attovia Therapeutics, Inc. (the "Company") issued a press release reporting its financial results for the second quarter ended June 30, 2026.

  • Charter amendmentAug 6, 2026

    On August 6, 2026, Attovia Therapeutics, Inc. (the "Company") filed its Amended and Restated Certificate of Incorporation (the "Charter") with the Secretary of State of the State of Delaware...in connection with the closing of the initial public offering (the "Offering") of shares of the Company's common stock.

About Attovia Therapeutics

Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.

Ticker
ATTO
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
Aug 5, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Attovia Therapeutics IPO price?

$17.00 a share.

When did Attovia Therapeutics go public?

Attovia Therapeutics listed on Nasdaq on Aug 5, 2026 under the ticker ATTO.

How much did the Attovia Therapeutics IPO raise?

$289M, before any underwriters' option.

How did Attovia Therapeutics open on its first day?

ATTO first traded at $21.00, +23.53% from the IPO price of $17.00.

How did ATTO close on its first day?

Its last regular-session trade was $21.96, +29.18% from the IPO price of $17.00.

What was the ATTO first-day trading range?

$20.21 to $22.79 in the regular session.

How many ATTO shares traded on the first day?

4.71M shares in the regular session.

How many shares did Attovia Therapeutics sell in its IPO?

17M shares.

How did ATTO do against the market on its first day?

ATTO rose 4.6% from its first trade to the last trade of the session. That is 5.0 points better than the market (QQQ, the Nasdaq-100 ETF).

What exchange is ATTO listed on?

Attovia Therapeutics lists on Nasdaq under the ticker ATTO.

Build with Massive

Get the ATTO data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/ATTO/range/5/minute
Market cap/v3/reference/tickers/ATTO
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.